News on Medial

PharmEasy Investor Marks Down Its Valuation To $456 Mn

Inc42 · 3m

PharmEasy's valuation has plummeted from a peak of $5.6 billion to approximately $456 million, according to investor Janus Henderson's recent filing. The asset manager now values its 12.9 million shares in the Indian online pharmacy at about $766,043, a significant drop from the original $9.4 million investment. This decline reflects the broader trend of valuation markdowns affecting Indian unicorns.